{
    "code": "01021272",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01021272",
    "time": "2020-02-25 03:02:22",
    "許可證字號": "衛署藥製字第021272號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/05\/25",
    "發證日期": "69\/04\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102127200",
    "中文品名": "來縮酵素錠",
    "英文品名": "LYSOZYME TABLETS",
    "適應症": "副鼻腔炎、鼻出血、咽喉頭炎、口內炎、中耳炎、血痰、喀血、粘膿液排出困難、喀痰困難、手術中、手術後出血",
    "劑型": "110錠劑",
    "包裝": "瓶裝 罐裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 1G不得製造",
        "申請商名稱": "6201157697  嘉林藥品有限公司",
        "申請商地址": "台北市士林區通河東街1段110號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4400001310",
            "成分名稱": "LYSOZYME CHLORIDE",
            "含量描述": "30",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ]
}